Financials

  • Market Capitalization 1.49 B
  • Employee 749
  • Founded 1987
  • CEO John C. Jacobs
  • Website www.novavax.com
  • Headquarter Delaware, United States
  • FIGI BBG000NVSBL7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
2.6
Price to sales ratio
1.04

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2181
AVBP
ArriVent BioPharma, Inc. - Common Stock
31.00 USD-0.45%+5.19%+3.58%+61.63%1.53 B USD
2189
INVA
Innoviva, Inc. - Common Stock
20.96 USD-1.32%+0.29%-3.68%+17.62%1.51 B USD
2211
REPL
Replimune Group, Inc. - Common Stock
15.60 USD-1.76%+12.55%+197.14%+191.04%1.47 B USD
2219
CGEM
Cullinan Therapeutics, Inc. - Common Stock
22.60 USD-1.09%+4.05%+28.05%+195.42%1.45 B USD

Frequently asked questions about Novavax Inc

What is the Novavax Inc stock price today?

The current price of Novavax Inc (NVAX) is 9.05. Over the past 24 hours, the stock has changed by -1.74%. Follow the NVAX chart for real-time price dynamics.

What is the stock ticker of Novavax Inc?

Novavax Inc trades under the ticker NVAX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Novavax Inc stock going up?

NVAX has changed by +7.23% over the last week, +24.14% over the last month, and +19.71% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Novavax Inc?

Novavax Inc currently has a market capitalization of 1.49 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Novavax Inc release financial reports?

Yes. You can track Novavax Inc financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were Novavax Inc earnings last quarter?

Last quarter, Novavax Inc reported earnings of -0.32 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Novavax Inc revenue for the last quarter?

Novavax Inc reported quarterly revenue of 56.7 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Novavax Inc net income for the last quarter?

Novavax Inc reported net income of -53.39 M for the last quarter. The previous quarter showed -9.49 M, which means net income changed by -462.50%.

How many employees does Novavax Inc have?

As of the latest available data, Novavax Inc has 749 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Novavax Inc stock?

You can buy Novavax Inc (NVAX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Novavax Inc stock?

Investing in Novavax Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NVAX chart and related analysis on metatrader.com as part of your research.

Novavax, Inc. - Common Stock

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus, avian flu, shingles, Clostridioides difficile, and malaria. Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine.

News